Detalhe da pesquisa
1.
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
Oncotarget
; 8(16): 27145-27154, 2017 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28423702
2.
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
JCO Precis Oncol
; 20172017.
Artigo
Inglês
| MEDLINE | ID: mdl-30761385